Here, a significant difference emerges
(NYSE: ANVS) (Annovis or the Company), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimers disease (AD) and Parkinsons disease (PD), today announced new preclinical data demonstrating the synergistic effect of its lead compound, buntanetap, when combined with the glucagon-like peptide 1 (GLP-1) agonist dulaglutide (Trulicity) in a mouse model of Alzheimers disease
Journal of Clinical Gastroenterology, 46 (Suppl.), S18-26
The FDA MedWatch page maintains updated lists of recalled and counterfeit pharmaceutical products
RiaGev was found to improve stress resistance by boosting ATP, NAD, and glutathione levels, which is associated with improvements to mitochondrial function
Some individuals may experience heightened anxiety or sleep disturbances when treated with the injections containing phentermine (11)